Allogene Therapeutics Inc to Host Virtual CD19 Forum Transcript
Hello, and welcome to the Allogene Therapeutics CD19 Forum. My name is Christine Cassiano, and I'm the Chief Communications Officer at Allogene. As this forum and the upcoming ASCO 2021 Annual Meeting are being held virtually by necessity, I'd like to take a few moments to talk about what we have in store for today.
First, we'll be making certain forward-looking statements during this program. These may include statements regarding the success and timing of our ongoing and planned clinical trials, data presentations, regulatory filings and future research and development efforts, among other things. These forward-looking statements are based on current information and assumptions and expectations that are subject to change.
Please also review our forward-looking statement in the slide deck, which will be accessible on our website in the Investor Relations section at the conclusion of this presentation and a full description of potential risk factors found in our latest SEC filings. You are cautioned not to
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
